Abstract:Ti Wu, 1, &ast Haipeng Zhang, 2, &ast Xiaolin Tian, 3 Yang Cao, 2 Dianjun Wei, 4 Xiangkun Wu 4 1 Department of Neurology, Tianjin Medical University General Hospital, Tianjin, People's Republic of China; 2 Department of Clinical Laboratory, The Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China; 3 Department of Neurology, The Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China; 4 Department of Clinical Laboratory, Hebei Yanda Hospital, Langfang, Hebei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiangkun Wu Tel +8615613682051 Email Purpose: To evaluate the association between neutrophil-to-lymphocyte ratio (NLR) and stroke-associated pneumonia (SAP) in patients with acute ischemic stroke (AIS) without fever and to clarify whether NLR has an advantage over high-sensitivity C-reactive protein (hs-CRP) in predicting SAP. Patients and Methods: A total of 434 patients with AIS without fever were assessed in this study. Multivariable analysis was used to evaluate the relationship between NLR and SAP, and the receiver operating characteristic (ROC) curve was used to compare the predictive value of NLR and hs-CRP. Results: Among the total patients, 18 (4.1%) developed SAP. After adjusting for confounders, NLR (adjusted odds ratio [aOR] = 1.60; 95% confidence interval [CI], 1.30– 1.96; p < 0.001) remained independently associated with an increased risk of SAP. In addition, the area under the curve (AUC) of NLR (0.862 [0.826– 0.893]) was higher than that of hs-CRP (0.738 [0.694– 0.779]). Conclusion: We found that compared with hs-CRP, NLR was significantly associated with the occurrence of SAP in patients with AIS without fever and showed a more effective predictive value for SAP. Keywords: stroke, pneumonia, neutrophil, lymphocyte, high-sensitivity C-reactive protein, inflammation Stroke-associated pneumonia (SAP), defined as new onset pneumonia within 7 days after stroke, is a common complication in patients with acute ischemic stroke (AIS). 1 It has been reported that 7–38% of patients with stroke experience SAP. 2–6 For these patients, not only do the length of hospital stay and cost of hospitalization increase significantly, but the risks of disability and death also greatly increase. 7,8 It is well known that pyrexia is key in the diagnosis of pneumonia; however, studies have shown that 25–66% of patients with SAP may not have pyrexia. 9,10 This may make clinicians ignore the infection. Therefore, a simple and effective biomarker is needed to quickly identify SAP in afebrile patients. Neutrophil-to-lymphocyte ratio (NLR), calculated by dividing the absolute neutrophil count by the absolute lymphocyte count, is a novel marker of systemic inflammation and infection. 11,12 C-reactive protein (CRP), one of the most accessible and widely used biomarkers, also plays a key role in the identification and evaluation of infections. 13,14 High-sensitivity C-reactive protein (hs-CRP) is a sensitive marker of inflammation, it detects low concentrations of CRP using a high-sensitivity assay technique. 15 Several studies have demonstrated that high NLR and CRP levels could predict SAP in patients with AIS. 16,17 At the same time, elevated CRP has also been shown to improve the diagnostic accuracy of the current SAP algorithms, independent of pyrexia. 18 However, the predictive value of hs-CRP and NLR in patients with AIS without fever remains unknown. In this study, we aimed to evaluate the association between NLR and SAP in AIS patients without fever and to clarify whether NLR has an advantage over hs-CRP in predicting SAP. This study was approved by the Ethics Committee of The Second Hospital of Tianjin Medical University. We retrospectively studied all patients with AIS who were admitted to the neurology ward of The Second Hospital of Tianjin Medical University from November 2018 to October 2020. Computed tomography (CT) or magnetic resonance imaging (MRI) was used to confirm the diagnosis of AIS. Patients were eligible for inclusion if they were ≥ 18 years of age and had onset of symptoms ≤ 72 h at recruitment. The exclusion criteria were (1) patients with severe hepatic or renal diseases; (2) having recently undergone major trauma or surgery; (3) a history of a malignant tumor, hematologic disease, or immunosuppressive treatment; (4) temperature ≥ 38°C at any one time within 7 days of stroke onset; (5) active infection at admission or incomplete medical records. The demographic and -Abstract Truncated-

The Relationship Between Serum YKL-40 Levels on Admission and Stroke-Associated Pneumonia in Patients with Acute Ischemic Stroke

Prognostic Performance of Serum YKL-40 for One-Year Clinical Outcomes in Acute Ischemic Stroke

Predictive Value of Serum Inflammatory Factors and FT3 for Stroke-Associated Pneumonia in Patients With Acute Ischemic Stroke

High Fibrinogen to Albumin Ratio: A Novel Marker for Risk of Stroke-Associated Pneumonia?

Hypersensitive C‐reactive protein‐albumin ratio is associated with stroke‐associated pneumonia and early clinical outcomes in patients with acute ischemic stroke

Association of Platelet-to-Lymphocyte Ratio with Stroke-Associated Pneumonia in Acute Ischemic Stroke

Novel Predictors of Stroke-Associated Pneumonia: A Single Center Analysis

Value of Combining of the NLR and the Fibrinogen Level for Predicting Stroke-Associated Pneumonia

Comparison of the Predictive Value of Inflammatory Biomarkers for the Risk of Stroke-Associated Pneumonia in Patients with Acute Ischemic Stroke

Risk factors for acute stroke-associated pneumonia and prediction of neutrophil-to-lymphocyte ratios

Association between fibrinogen levels and stroke-associated pneumonia in acute ischemic stroke patients

Systemic inflammatory response index as a predictor of stroke-associated pneumonia in patients with acute ischemic stroke treated by thrombectomy: a retrospective study

Predictive value of the systemic immune inflammation (SII) index for stroke‐associated pneumonia

Serum Albumin As a Potential Predictor of Pneumonia after an Acute Ischemic Stroke.

Individualized Prediction of Stroke-Associated Pneumonia and its severity for Patients with Acute Ischemic Stroke

15-Hydroxyprostaglandin Dehydrogenase Is a Predictor of Stroke-Associated Pneumonia

High fibrinogen-prealbumin ratio (FPR) predicts stroke-associated pneumonia

High Monocyte-To-Lymphocyte Ratio Is Associated With Stroke-Associated Pneumonia

Clinical significance of albumin to globulin ratio among patients with stroke-associated pneumonia

Neutrophil-to-Lymphocyte Ratio Better Than High-Sensitivity C-Reactive Protein in Predicting Stroke-Associated Pneumonia in Afebrile Patients

Increased serum interleukin-34 levels as a novel diagnostic and prognostic biomarker in patients with acute ischemic stroke